AstraZeneca PLC (AZN)
202.83
-0.66
(-0.32%)
USD |
NYSE |
Apr 06, 16:00
201.08
-1.75
(-0.86%)
Pre-Market: 04:09
AstraZeneca SG&A Expense (TTM) : 580.07M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| GSK Plc | 11.99B |
| Mereo BioPharma Group Plc | 23.06M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Biodexa Pharmaceuticals Plc | 6.375M |
| BioNTech SE | 709.95M |